Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Cellular senescence
Research brief

Blue light and senescence markers in human dermal fibroblasts

In cultured human dermal fibroblasts, blue light raised markers linked to DNA damage and cellular senescence, including p21 and senescence-associated beta-galactosidase activity, compared with non-irradiated control cells. [1]

Automatic summary · not editorially reviewed

The key findings

  1. Human dermal fibroblasts were exposed to varying doses of blue light and compared with a non-irradiated control group. [1]

  2. Blue light increased γH2AX expression (p ≤ 0.0001), which the authors read as indicating DNA double-strand breaks. [1]

  3. Senescence-associated beta-galactosidase activity increased, with 25 J/cm² the minimum dose reaching statistical significance versus non-irradiated controls (p ≤ 0.01). [1]

The source at a glance

Study type / format
Laboratory cell-culture experiment (abstract)
Population / context
Cultured human dermal fibroblasts (HDFn)
Summary based on
Study abstract
Original publication
September 22, 2026

Blue light doses tested in cultured fibroblasts

The study exposed human dermal fibroblasts to varying doses of blue light, then measured known senescence markers with immunofluorescence and gene expression analysis by qPCR. Senescence-associated beta-galactosidase activity was assessed with a staining kit. The comparison was against a non-irradiated control group. This was laboratory work on cultured cells, not a study of people or of skin aging over time.

Supporting source [1]

DNA damage and senescence markers rose after exposure

Blue light increased γH2AX expression (p ≤ 0.0001), which the authors read as indicating DNA double-strand breaks. The senescence marker p21 rose in both immunofluorescence and gene expression, with a 15-fold increase in cells exposed to 50 J/cm² blue light (p ≤ 0.001). NFκB showed a dose-dependent increase in nuclear translocation, maximal at 25 J/cm² and 50 J/cm² (both p ≤ 0.0001). Senescence-associated beta-galactosidase activity also increased, with 25 J/cm² the minimum dose reaching statistical significance versus non-irradiated controls (p ≤ 0.01).

Supporting source [1]

Interpretation limited to cell-culture findings

The authors conclude that blue light may induce both mitochondrial and nuclear DNA damage and, together with the raised senescence markers and beta-galactosidase activity, could induce cellular senescence. They also suggest a possible bystander effect in neighbouring cells via NFκB nuclear translocation and associated reactive oxygen species production. These are interpretations of cultured-cell results; the abstract reports no human participants, no clinical skin outcomes and no test of whether such effects occur in living skin. The authors call for further research.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. Findings come from cultured human dermal fibroblasts, not from people, and the abstract reports no clinical skin outcomes. Suggested bystander effects and senescence induction are interpretations, not established causal effects in living skin.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Blue Light Exposure Induces Changes Associated With Senescence and Skin Aging in Human Dermal Fibroblasts.

McNish H, Mathapathi MS, Figlak K, Damodaran A, Birch-Machin M. · europepmc.org · September 22, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    exposing HDFn to varying doses of blue
  2. Finding 2 ↑

    Blue light induces increased γH2AX expression
  3. Finding 3 ↑

    25 J/cm being the minimum dose required

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…